Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TELA TELA Bio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.19 +3.5% | $15.65 -4.0% |
| StockIQ Score | 54C- Moderate Risk: High | 42D Weak Risk: Medium |
| Technical | 69B- | 36F |
| Fundamental | 31F | 35F |
| Growth | 65B- | 50C- |
| Fair Value | 50C- | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
TELA Bio outperforms Ascentage Pharma in most categories. Its investor score (54 vs. 42) and technical score (69 vs. 36) are significantly higher, showing stronger market sentiment and short-term price trends. TELA also has a more favorable rating (Moderate vs. Weak), though Ascentage Pharma’s valuation score (38 vs. 50) is slightly better. Growth scores are close (65 vs. 50), but TELA leads overall.
